Walleye Trading’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.39M Buy
25,690
+19,259
+299% +$1.81M ﹤0.01% 1741
2026
Q1
$572K Buy
+6,431
New +$661K ﹤0.01% 2509
2025
Q4
Sell
-11,721
Closed -$1.18M 4348
2025
Q3
$1.16M Buy
+11,721
New +$1.25M ﹤0.01% 2170
2025
Q2
Sell
-4,691
Closed -$474K 4245
2025
Q1
$427K Buy
+4,691
New +$525K ﹤0.01% 2623
2024
Q4
Sell
-17,904
Closed -$2.04M 4258
2024
Q3
$2.13M Buy
17,904
+6,664
+59% +$613K ﹤0.01% 1643
2024
Q2
$903K Sell
11,240
-3,185
-22% -$291K ﹤0.01% 2144
2024
Q1
$1.33M Buy
+14,425
New +$1.38M ﹤0.01% 2011
2023
Q4
Sell
-21,903
Closed -$2.21M 5082
2023
Q3
$2.38M Buy
+21,903
New +$2.42M 0.01% 1654

Other funds holding BNTX

Walleye Trading's BNTX Position: Q2 2026 in Review

Walleye Trading increased its BioNTech (BNTX) stake by 299% in Q2 2026, buying an estimated $1.81M and bringing the position to 25,690 shares worth $2.39M. The position accounts for ﹤0.01% of the portfolio, ranked #1741.

Walleye Trading first reported a position in BNTX in Q3 2023 and has held it in 8 quarters since. 112 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Walleye Trading held 25,690 shares of BioNTech worth $2.39M as of Q2 2026.
  • Walleye Trading bought 19,259 BioNTech shares in Q2 2026, an estimated $1.81M.
  • BioNTech made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #1741 holding.
  • Walleye Trading first reported a position in BioNTech in Q3 2023 and has held it in 8 quarters since.
  • 112 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.